Graft SurvivalTissue DonorsLiving DonorsKidney TransplantationGraft RejectionLiver TransplantationTransplantation, HomologousCadaverHistocompatibility TestingSurvival RateGraft vs Host DiseaseTreatment OutcomeRetrospective StudiesCell SurvivalBone Marrow TransplantationImmunosuppressive AgentsTime FactorsPancreas TransplantationCorneal TransplantationTissue and Organ ProcurementLymphocyte DepletionHeart TransplantationBlood DonorsGraft Occlusion, VascularSurvival AnalysisKeratoplasty, PenetratingTacrolimusDisease-Free SurvivalSkin TransplantationImmunosuppressionDelayed Graft FunctionCyclosporineCold IschemiaFollow-Up StudiesOrgan PreservationBrain DeathPostoperative ComplicationsIslets of Langerhans TransplantationSurvivalKaplan-Meier EstimateMycophenolic AcidTransplantsTransplantation ToleranceReoperationTransplantation, HeterotopicGraft Enhancement, ImmunologicLiver FailureProportional Hazards ModelsDeathTransplantation ImmunologyPrimary Graft DysfunctionAntilymphocyte SerumBlood Vessel ProsthesisHLA AntigensRisk FactorsKidney Failure, ChronicIsoantibodiesRats, Inbred LewTissue and Organ HarvestingMice, Inbred C57BLAzathioprineOrgan Preservation SolutionsHistocompatibilityMice, Inbred BALB CPolytetrafluoroethyleneKidneyTransplantationRecurrenceMultivariate AnalysisProspective StudiesTransplantation, IsogeneicDonor SelectionCreatinineBiopsyAnastomosis, SurgicalIsoantigensPrognosisAge FactorsCorneal NeovascularizationOrgan TransplantationWaiting ListsVascular PatencyAntibodies, MonoclonalComplement C4bFetal Tissue TransplantationCohort StudiesAllograftsActuarial AnalysisImmunoconjugatesRaffinoseRisk AssessmentAcute DiseaseDrug Therapy, CombinationIncidencePolyethylene TerephthalatesSaphenous VeinT-LymphocytesBlood Vessel Prosthesis ImplantationTransplantation, HeterologousApoptosis